Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMG3 | ISIN: SE0018397184 | Ticker-Symbol: 5JG
München
15.01.25
09:03 Uhr
0,052 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
TENEO AI AB Chart 1 Jahr
5-Tage-Chart
TENEO AI AB 5-Tage-Chart
GlobeNewswire (Europe)
3 Leser
Artikel bewerten:
(0)

Teneo AI AB: Teneo AI publishes preliminary results and key figures for the fourth quarter 2024 and full year 2024

Finanznachrichten News

Teneo.ai (SSME:TENEO), the enterprise AI product provider for contact centers, today announces preliminary results and the successful fulfilment of two long term financial targets during the fourth quarter 2024. Teneo.ai discloses this information since the company considers it to significantly deviate from current market expectations.

Key KPI's and Results for the Period

Teneo.ai discloses the following preliminary and non-audited results and KPI's of the fourth quarter 2024:

OCT-DEC 2024JUL-SEP 2024OCT-DEC 2023JAN-DEC 2024JAN-DEC 2023
Net sales (MSEK)26.521.215.884.160.5
Recurring revenues (MSEK)26.321.115.783.560.0
ARR (MSEK)103.984.363.0103.963.0
SaaS ARR (MSEK)75.154.331.075.131.0
SaaS API Calls Revenues (MSEK)14.89.33.836.315.9
SaaS API Call Volumes (average Million)60.341.018.160.318.1
NRR %135%127%148%135%148%
Gross margin %80%79%77%79%67%
Gross margin % (excl. commission)87%83%75%83%72%
EBITDA adjusted (MSEK) -1.7-5.9-5.8-22.3-50.7
Earnings per share, SEK -0.0-0.1-0.2-0.2-0.6
Cash flow from operating activities before
changes in working capital
-1.3-16.4-8.6-30.5-53.8

Teneo.ai has experienced strong growth in API call volumes and revenues YoY and QoQ in the fourth quarter 2024 and versus the third quarter 2024. The strong growth YoY for different key metrics is reported below:

  • SaaS API Call revenues amounted to 14.8 MSEK (3.8), +294%
  • SaaS API Call Volumes average amounted to 60.3 million (18.1), +234 %
  • SaaS ARR amounted to 75.1 MSEK (31.0), +142%
  • Recurring revenues amounted to 26.3 MSEK (15.7), +67%
  • Total ARR amounted to 103.9 MSEK (63.0), +65%

      Two Financial Targets Fulfilled in the Period

      The two long term financial targets that were fulfilled during the fourth quarter 2024 are:

      • API call volumes of 1 bn annualized during 2024

      During one month in the fourth quarter 2024, the annualized API call volumes, for SaaS and non-SaaS volumes combined, amounted to 1 billion API calls. The average annualized API call volumes in the fourth quarter amounted to 901 million (440), equivalent to a YoY growth of 105%. This is a key KPI for our operations and the more API calls generated, the more revenues for the company.

      • Positive cash flow from operations during 2024

      During one month in the fourth quarter 2024, the company reported a net cash flow of +2.4 MSEK. The adjusted EBITDA in the fourth quarter amounted to -1.7 MSEK (-5.8 MSEK). Higher revenue volumes in the fourth quarter 2024 improved profitability and cash flow generation during the quarter. Cash & bank position on December 31, 2024, amounted to 18.4 MSEK.

      Fourth Quarter Report

      The full report will, as previously announced, be disclosed on February 20, 2025.

      Subscribe to Stay Updated

      To receive our company's press releases in your email and stay up to date, subscribe by filling out the form in this link.

      This disclosure contains information that Teneo AI AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 14-01-2025 18:30 CET.

      For further information, please contact:

      Per Ottosson, CEO, Teneo.ai
      Email: per.ottosson@teneo.ai

      Fredrik Törgren, CFO, Teneo.ai
      e-Mail: fredrik.torgren@teneo.ai

      About Teneo AI AB

      Teneo.ai (SSME:TENEO) is at the forefront of AI-driven automation for voice and text-based customer service. Our Teneo platform leverages cutting-edge Conversational AI, Generative AI, and Large Language Models to enhance the efficiency and effectiveness of customer interactions. We simplify Voice AI integration, ensuring a seamless experience that reduces losses in automated conversations and maximizes the value of existing technology investments.

      Our innovative solutions help businesses expand their customer base, boost revenue, and reduce churn, enabling the realization of the Agentless Contact Center concept. This approach delivers tangible ROI through lower cost as contact center agents are freed to conduct higher value tasks, improved customer satisfaction (CSAT), first contact resolution (FCR), and call containment.

      Proudly serving global leaders like AT&T, HelloFresh, Swisscom, and Telefónica, Teneo.ai has revolutionized customer service automation, directly automating up to 40% of operations and achieving up to 50% cost savings. Our patented technology integrates effortlessly with any Conversational AI platform, supporting both chat and voice applications. This integration enhances critical metrics such as growth, FCR, CSAT, and Net Promoter Score (NPS), ensuring our clients achieve superior outcomes in customer service.

      Teneo.ai is listed on Nasdaq First North Growth Market in Stockholm with short name TENEO. Redeye is the Company's Certified Adviser.

      Learn more at?www.teneo.ai/investors.


      © 2025 GlobeNewswire (Europe)
      Gewinner im Megamarkt
      Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

      Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

      Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
      Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.